Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 557

    1.

    Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C.

    Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN.

    Diabetes Care. 2007 May;30(5):1120-4. Epub 2007 Mar 2.PMID: 17337498 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

    Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

    Diabetes Care. 2001 Mar;24(3):465-71.PMID: 11289469 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Fasting plasma glucose in screening for NIDDM in the U.S. and Israel.

    Modan M, Harris MI.

    Diabetes Care. 1994 May;17(5):436-9.PMID: 7741837 [PubMed - indexed for MEDLINE]Related articles

    5.

    Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience.

    Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J; AusDiab.

    Diabetes Care. 2004 Feb;27(2):367-71.PMID: 14747215 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM.

    Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC.

    Diabetes Care. 1996 Sep;19(9):972-8.PMID: 8875091 [PubMed - indexed for MEDLINE]Related articles

    7.

    Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.

    Jesudason DR, Dunstan K, Leong D, Wittert GA.

    Diabetes Care. 2003 Feb;26(2):485-90.PMID: 12547886 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.

    Mannucci E, Ognibene A, Sposato I, Brogi M, Gallori G, Bardini G, Cremasco F, Messeri G, Rotella CM.

    Acta Diabetol. 2003 Dec;40(4):181-6.PMID: 14740278 [PubMed - indexed for MEDLINE]Related articles

    9.

    Analysis of fasting plasma glucose values for optimal detection of abnormal responses on the oral glucose tolerance test in at-risk study subjects.

    Robles-Osorio L, Aguilar-Salinas CA, Mehta R, Gómez-Pérez FJ, Rull JA.

    Endocr Pract. 2007 Oct;13(6):583-9.PMID: 17954413 [PubMed - indexed for MEDLINE]Related articles

    10.

    Screening for diabetes mellitus--a two-step approach in individuals with impaired fasting glucose improves detection of those at risk of complications.

    Tai ES, Lim SC, Tan BY, Chew SK, Heng D, Tan CE.

    Diabet Med. 2000 Nov;17(11):771-5.PMID: 11131101 [PubMed - indexed for MEDLINE]Related articles

    11.

    A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

    Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

    J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491. PMID: 16918824 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of screening tests for non-insulin-dependent diabetes mellitus.

    Hanson RL, Nelson RG, McCance DR, Beart JA, Charles MA, Pettitt DJ, Knowler WC.

    Arch Intern Med. 1993 Sep 27;153(18):2133-40.PMID: 8379805 [PubMed - indexed for MEDLINE]Related articles

    13.

    Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

    Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

    Diabetes Care. 2006 Jul;29(7):1619-25.PMID: 16801588 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Diagnostic and therapeutic implications of relationships between fasting, 2-hour postchallenge plasma glucose and hemoglobin a1c values.

    Woerle HJ, Pimenta WP, Meyer C, Gosmanov NR, Szoke E, Szombathy T, Mitrakou A, Gerich JE.

    Arch Intern Med. 2004 Aug 9-23;164(15):1627-32.PMID: 15302632 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The fasting plasma glucose cut-point predicting a diabetic 2-h OGTT glucose level depends on the phenotype.

    Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Carstensen B, Tajima N, Iwamoto Y, Borch-Johnsen K, Borch-Jonsen K; DECODA Study Group. Diabetes Epidemiology: Collaborative Analysis of Diagnostic criteria in Asia; International Diabetes Epidemiology Group.

    Diabetes Res Clin Pract. 2002 Jan;55(1):35-43. Erratum in: Diabetes Res Clin Pract 2002 Oct;58(1):73. PMID: 11755477 [PubMed - indexed for MEDLINE]Related articles

    16.

    [Diagnosing type 2 diabetes mellitus: in primary care, fasting plasma glucose and glycosylated haemoglobin do the job]

    Jimeno Mollet J, Molist Brunet N, Franch Nadal J, Morató Griera J, Otzet Gramunt I, Pons Barro P.

    Aten Primaria. 2004 Sep 30;34(5):222-8. Spanish. PMID: 15456566 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.

    Franciosi M, De Berardis G, Rossi MC, Sacco M, Belfiglio M, Pellegrini F, Tognoni G, Valentini M, Nicolucci A.

    Diabetes Care. 2005 May;28(5):1187-94.PMID: 15855587 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria.

    Davidson MB, Schriger DL, Peters AL, Lorber B.

    JAMA. 1999 Apr 7;281(13):1203-10. Erratum in: JAMA 1999 Jun 16;281(23):2187. PMID: 10199430 [PubMed - indexed for MEDLINE]Related articles

    20.

    Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population.

    Agarwal MM, Hughes PF, Punnose J, Ezimokhai M.

    Diabet Med. 2000 Oct;17(10):720-6.PMID: 11110505 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data